抗生物質バイオシンセシス中の非リボソームペプチド合成酵素によるβ-ラクタム形成
Nicole M Gaudelli1, Darcie H Long1, Craig A Townsend1
1Department of Chemistry, Johns Hopkins University, Baltimore, Maryland 21218, USA.
Nature
|January 28, 2015
まとめ
非リボソーム性ペプチド合成酵素はペプチドを組み立て,ノカルディシン抗生物質において重要なベータ・ラクトーム環を形成する. この新しいメカニズムは,他のベータ・ラクタム経路と異なるもので,人工ペプチドの新たな可能性を提供します.
科学分野:
- バイオケミストリー バイオケミストリー
- 自然製品のバイオシンセシス
- 酵素学 酵素学とは
背景:
- 非リボソームペプチド合成酵素 (NRPS) は,多様な生物活性ペプチドを合成する大型酵素です.
- バンコマイシンやペニシリンなどの抗生物質を含む多くの天然製品は,NRPS.から派生しています.
- ベータ・ラクタム環は,多くの抗生物質の重要な構造モチーフである.
研究 の 目的:
- ノカルディシン抗生物質のバイオシンセシスに関与する新しいNRPS活性を調べる.
- NRPSによるベータ・ラクタム環形成のメカニズムを解明する.
- このNRPS活動のペプチド工学における潜在的な応用を探求する.
主な方法:
- NRPSの活動を研究するための生化学的分析.
- 酵素ドメイン分析. 酵素ドメイン分析.
- 機械学的研究と実験的検証をサポートする.
主要な成果:
- セリンを含むペプチドをアセンブルする前例のないNRPS活動の発見.
- ベータ・ラクタム環合成に責任を持つヒスティジンに富んだ凝縮ドメインの特定.
- 既知の経路とは異なるベータ・ラクタム環形成の新たなメカニズムの解明.
結論:
- ノカルディシンにおけるβ-ラクタム環形成のための新しいNRPSメカニズムが特定されました.
- この発見は,NRPSの機能とベータ・ラクタム生物合成の理解を広げています.
- 発見されたNRPSの活動は,新しい生物活性ペプチドとプロテアゼ阻害剤の設計の可能性を秘めている.
関連する概念動画
Inhibitors of Gram-positive Cell Wall Synthesis
119
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
119
Production of Antibiotics
198
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
198
Inhibitors of Bacterial Protein Synthesis
81
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
81
Biosynthesis in Bacteria
1.0K
Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...
1.0K
Peptidoglycan Synthesis
4.6K
Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan...
4.6K
Production of Pharmaceuticals
77
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
77


